Liver International logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 26, Number 7, September 2006

< previous issue | all issues | next issue >

Quality of life in hepatitis C
pp. 755-765(11)
Authors: Strauss, Edna; Dias Teixeira, Maria Cristina

Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients
pp. 766-773(8)
Authors: Chen, Chien-Hung; Chang, Ting-Tsung; Cheng, Ken-Sheng; Su, Wei-Wen; Yang, Sheng-Shun; Lin, Hans Hsienhong; Wu, Shun-Sheng; Lee, Chuan-Mo; Changchien, Chi-Sin; Chen, Chien-Jen; Sheu, Jin-Chuan; Chen, Ding-Shinn; Lu, Sheng-Nan

Decreased expressions of hepsin in human hepatocellular carcinomas
pp. 774-780(7)
Authors: Chen, Chien-Hung; Su, Kang-Yi; Tao, Mi-Hua; Lin, Shu-Wha; Su, Ying-Hui; Tsai, Yu-Chiu; Cheng, Kuang-Chun; Jeng, Yung-Ming; Sheu, Jin-Chuan

Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings
pp. 781-788(8)
Authors: Nagaoka, Sakae; Itano, Satoshi; Ishibashi, Masatoshi; Torimura, Takuji; Baba, Kenkichi; Akiyoshi, Junji; Kurogi, Junichi; Matsugaki, Satoru; Inoue, Kinya; Tajiri, Nobuyoshi; Takada, Akio; Ando, Eiji; Kuromatsu, Ryoko; Kaida, Hayato; Kurogi, Mina; Koga, Hironori; Kumashiro, Ryukichi; Hayabuchi, Naofumi; Kojiro, Masamichi; Sata, Michio

Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with α-fetoprotein and protein induced by vitamin K absence or antagonist-II
pp. 789-795(7)
Authors: Yano, Yoichi; Yamashita, Fumihiko; Kuwaki, Kotaro; Fukumori, Kazuta; Kato, Osamu; Yamamoto, Hiroshi; Ando, Eiji; Tanaka, Masatoshi; Sata, Michio

Hepatitis B virus genotypes, precore and core promoter variants among predominantly Asian patients with chronic HBV infection in a Canadian center
pp. 796-804(9)
Authors: Fung, Scott K.; Wong, Florence S. H.; Wong, David K. H.; Hussain, Munira T.; Lok, Anna S. F.

Treatment of chronic hepatitis delta with pegylated interferon-α2b
pp. 805-810(6)
Authors: Erhardt, Andreas; Gerlich, Wolfram; Starke, Christine; Wend, Ulrike; Donner, Andreas; Sagir, Abdurrahman; Heintges, Tobias; Häussinger, Dieter

Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology
pp. 811-816(6)
Authors: Kornberg, Arno; Küpper, Bernadett; Tannapfel, Andrea; Thrum, Katharina; Bärthel, Erik; Settmacher, Utz

Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study
pp. 817-826(10)
Authors: Tsamandas, Athanassios C.; Syrokosta, Ioulia; Thomopoulos, Konstantinos; Zolota, Vassiliki; Dimitropoulou, Dimitra; Liava, Anna; Coupoulou, Anna Antona; Siagris, Dimitrios; Petsas, Theodore; Karatza, Chrisoula; Gogos, Charalambos A

Influence of Helicobacter pylori infection on iron accumulation in hepatitis C
pp. 827-833(7)
Authors: Sumida, Yoshio; Kanemasa, Kazuyuki; Yamaoka, Yoshio; Imamura, Shigeyoshi; Katoh, Naho; Nakashima, Toshiaki; Tachibana, Shunji; Mitsuyoshi, Hironori; Itoh, Yoshito; Okanoue, Takeshi

Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study
pp. 834-839(6)
Authors: Schepke, Michael; Appenrodt, Beate; Heller, Jörg; Zielinski, Julia; Sauerbruch, Tilman

The AST/ALT ratio as an indicator of cirrhosis in patients with PBC
pp. 840-845(6)
Authors: Nyblom, Helena; Björnsson, Einar; Simrén, Magnus; Aldenborg, Frank; Almer, Sven; Olsson, Rolf

Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients
pp. 846-855(10)
Authors: Berg, Christoph P.; Stein, Gerburg M.; Klein, Reinhild; Pascu, Maria; Berg, Thomas; Kammer, Winfried; Priemer, Martin; Nordheim, Alfred; Schulze-Osthoff, Klaus; Gregor, Michael; Wesselborg, Sebastian; Berg, Peter A.

Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease
pp. 864-871(8)
Authors: Lydatakis, Helen; Hager, Ieronymos Philippos; Kostadelou, Eyaggelia; Mpousmpoulas, Stavros; Pappas, Stavros; Diamantis, Ioannis

Intrahepatic activation of caspases in human fulminant hepatic failure
pp. 872-879(8)
Authors: Leifeld, Ludger; Nattermann, Jacob; Fielenbach, Magdalene; Schmitz, Volker; Sauerbruch, Tilman; Spengler, Ulrich

Wash-out of the non-heart-beating donor liver: a matter of flush solution and temperature?
pp. 880-888(9)
Authors: Bessems, Maud; Doorschodt, Benedict M.; Albers, Peter S.; Meijer, Alfred J.; van Gulik, Thomas M.

Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study
pp. 889-898(10)
Authors: Geerts, Anja M.; De Vriese, An S.; Vanheule, Eline; Van Vlierberghe, Hans; Mortier, Siska; Cheung, Kin-Jip; Demetter, Pieter; Lameire, Norbert; De Vos, Martine; Colle, Isabelle

Unexplained CK elevations in patients with nonalcoholic steatohepatitis
pp. 899-900(2)
Authors: GOGIA, S.; NEUSCHWANDER-TETRI, B. A.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page